| scholarly article | Q13442814 |
| P2093 | author name string | Amir Khan | |
| Ruxandra Draghia-Akli | |||
| Heather Attra | |||
| Henry Hebel | |||
| P2860 | cites work | Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154. | Q47593314 |
| Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines | Q47727853 | ||
| Priming of piglets against enterotoxigenic E. coli F4 fimbriae by immunisation with FAEG DNA. | Q47805238 | ||
| Improvement of DNA vaccine immunogenicity by a dual antigen expression system | Q47971522 | ||
| Purification of pharmaceutical-grade plasmid DNA by anion-exchange chromatography in an RNase-free process. | Q53641366 | ||
| Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex | Q56903886 | ||
| Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem | Q74072051 | ||
| Theoretical analysis of localized heating in human skin subjected to high voltage pulses | Q74243985 | ||
| Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis | Q74243989 | ||
| Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles | Q80507043 | ||
| A rapid alkaline extraction procedure for screening recombinant plasmid DNA | Q24614998 | ||
| At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain | Q30638046 | ||
| Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia | Q31002543 | ||
| Issues for improving multiplasmid DNA vaccines for HIV-1. | Q34619954 | ||
| Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors | Q34791491 | ||
| Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research | Q35089200 | ||
| Perspectives on plasmid-based gene therapy: challenges for the product and the process | Q35097555 | ||
| Plasmid DNA purification | Q35673340 | ||
| Electroporation for gene transfer to skeletal muscles: current status | Q35782833 | ||
| A prefilled injection device for outreach tetanus immunization by Bolivian traditional birth attendants | Q38550231 | ||
| Impact of intrinsic DNA structure on processing of plasmids for gene therapy and DNA vaccines. | Q40471003 | ||
| Large-scale capture and partial purification of plasmid DNA using anion-exchange membrane capsules | Q44375706 | ||
| Evaluation of an ion‐exchange membrane for the purification of plasmid DNA | Q44399492 | ||
| Integrated process for purification of plasmid DNA using aqueous two-phase systems combined with membrane filtration and lid bead chromatography | Q45177313 | ||
| Use of a Sindbis virus DNA-based expression vector for induction of protective immunity against pseudorabies virus in pigs | Q45722894 | ||
| Production of plasmid DNA for human gene therapy using modified alkaline cell lysis and expanded bed anion exchange chromatography | Q45866252 | ||
| Accelerated immune response to DNA vaccines | Q46301816 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 4607-4614 | |
| P577 | publication date | 2005-08-24 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device. | |
| P478 | volume | 24 |
| Q54359189 | A continuous cell alkaline lysis, neutralization, and clarification combination process for production of plasmid pUDK-HGF. |
| Q36288704 | Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice |
| Q41899321 | Antibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process |
| Q61822538 | DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice |
| Q37590348 | DNA vaccine manufacture: scale and quality |
| Q50653876 | Double-blinded, Placebo-controlled plasmid GHRH trial for cancer-associated anemia in dogs. |
| Q37622247 | Electrodes for in vivo localised subcutaneous electropulsation and associated drug and nucleic acid delivery |
| Q36981658 | Electroporation-based DNA immunisation: translation to the clinic |
| Q33346277 | Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens |
| Q80204825 | Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques |
| Q36428352 | Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation |
| Q34910424 | Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge |
| Q36704473 | Plasmid-based gene therapy of diabetes mellitus |
| Q36694825 | Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus. |
| Q38259502 | Production and purification of plasmid DNA vaccines: is there scope for further innovation? |
| Q84863673 | Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage |
Search more.